Skip to main content
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt flag Egypt · Delayed Price · Currency is EGP
5.68
+0.05 (0.89%)
At close: Nov 12, 2026

EGX:RMDA Financials Overview

Millions EGP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,4034,0962,7691,9221,4841,246
Revenue Growth
11.52%47.94%44.03%29.54%19.06%29.81%
Gross Profit
2,2461,9821,284904.06718.67576.82
Operating Income
1,019962.45725.44445.76342.26274.29
Net Income
340.73268.61363.84223.5228.91166.39
Earnings Per Share
0.170.130.180.110.120.08
EPS Growth
-14.23%-26.23%60.98%-3.52%41.22%70.69%

Revenue by Segment
Chart
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Sales of Pharmaceutical Products
3,8112,5871,7881,3521,169
Services Toll Manufacturing
284.79181.87134.01132.4477.49
Total
4,0962,7691,9221,4841,246

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
74.236.18254.39313.25428.82482.01
Total Debt
2,3262,4091,5661,114930.18879.94
Net Cash (Debt)
-2,252-2,372-1,312-801.18-501.37-397.93
Net Cash Growth
------
Net Cash Per Share
-1.11-1.18-0.65-0.40-0.26-0.20

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
270.21-43.67-306.92-44.529.35241.35
Capital Expenditures
-176.28-155.9-64.93-91.05-34.38-52.67
Free Cash Flow
93.93-199.57-371.85-135.54-5.03188.68
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
51.01%48.39%46.38%47.03%48.43%46.28%
Operating Margin
23.15%23.50%26.20%23.19%23.06%22.01%
Pretax Margin
11.32%10.35%19.00%17.03%22.13%18.74%
Profit Margin
7.74%6.56%13.14%11.63%15.43%13.35%
FCF Margin
2.13%-4.87%-13.43%-7.05%-0.34%15.14%

Dividends
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingNov '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.040-0.0400.051
Dividend Per Share Growth
-62.69%--20.71%-
Dividend Yield
0.71%-1.59%4.07%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
33.6724.7913.8011.0012.6314.42
Forward PE
17.869.1910.847.729.2510.10
P/FCF Ratio
122.92----12.72
PS Ratio
2.621.631.811.281.951.93